August 2018

Novel Cancer Vaccine May Improve Survival in Synovial Sarcoma

July 20, 2018

Clinical Trials in Progress

Investigators are hopeful that CMB305, a vaccine that boosts the immune response to tumor cells expressing the antigen NY-ESO-1, can improve survival outcomes for patients with synovial sarcoma.

Potent Hypomethylating Agent Is Tested in 2 Hematologic Malignancy Trials

July 20, 2018

Clinical Trials in Progress

Two randomized phase III clinical trials are designed to determine whether guadecitabine (SGI-110), a potent second-generation hypomethylating agent, could answer unmet medical needs for patients with certain types of blood cancer.